Search
NAFLD is the most common liver disease in the United States. It is thought to affect approximately 30 million people, 8.6 million of whom have the more severe form of the disease, NASH.
Fatty liver disease is when there is excess fat in the liver. This fat can be associated with inflammation or can just be isolated fat in the liver.
Presented by Dr. Wajahat Mehal, Professor of Medicine and Director of the Yale Weight Loss Program and Jessica Dean, Registered Dietician, Yale New Haven Health’s Fatty Liver Clinic.
Learn about steatotic (fatty) liver disease, including metabolic dysfunction-associated steatotic liver disease (MASLD) and its advanced form, metabolic dysfunction-associated steatohepatitis (MASH), their causes and key statistics.
Award-winning dietitian Kristin Kirkpatrick and hepatologist Dr. Ibrahim Hanouneh have teamed up for a life-changing program that will help you achieve optimal health.
See how two celebrities brought their personal struggles with liver disease into the national spotlight last year to raise awareness around this silent killer.
American Liver Foundation (ALF) proudly announces its 50th anniversary, marking five decades of unwavering commitment to advancing liver health, empowering liver patients and their families, providing groundbreaking public health initiatives and programs, and funding close to $30 million in critical research that supports and educates the 100 million Americans living with some form of liver disease.
American Liver Foundation (ALF) is pleased to announce a new partnership with Helio Genomics (Helio) that empowers millions of Americans to find out if they are at risk for, or already have, liver cancer.
Patty advocates in memory of her grandmother, who lost her life to liver cancer after facing barriers to care. This Hispanic Heritage Month, learn how you can help ensure families like Patty’s receive the education, resources, and early detection they deserve. Read her story now.
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, typically arising in the setting of chronic liver disease or cirrhosis.
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a liver condition characterized by fat accumulation in the liver linked to metabolic risk factors such as obesity, type 2 diabetes, and insulin resistance.
From newborns to older adults, liver health is under threat and this summer we’re focusing on three key areas that urgently need your help: obesity and metabolic dysfunction-associated steatotic liver disease (MASLD), living organ donors, and protecting newborns from hepatitis.